Subasumstat by Takeda Pharmaceutical for Relapsed Multiple Myeloma: Likelihood of Approval

Subasumstat is under clinical development by Takeda Pharmaceutical and currently in Phase II for Relapsed Multiple Myeloma.

Biden Health Watch; Pediatrician Killed on Bike; Olympic Medical Team Gets Uniform

Note that some links may require registration or subscription. Doctors are increasingly worried about President Biden’s health. (The New Yorker) Biden appeared to forget the

July 20, 2024

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the “entire history of Bangladesh,” said environmental historian Iftekhar Iqbal

October 25, 2023

Zimmer receives FDA clearance for robotic shoulder system

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Zimmer Biomet received 510(k) clearance

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.